Healthways Inc. (NASDAQ:HWAY)’s share price was up 4.1% during mid-day trading on Friday . The stock traded as high as $16.60 and last traded at $16.59, with a volume of 519,951 shares changing hands. The stock had previously closed at $15.93.

Several equities analysts recently issued reports on HWAY shares. FBR & Co started coverage on shares of Healthways in a research note on Friday, April 15th. They set an “outperform” rating and a $16.00 price objective on the stock. Barrington Research reduced their price objective on shares of Healthways from $15.00 to $14.00 and set an “outperform” rating on the stock in a research note on Friday, April 29th. Jefferies Group reissued a “hold” rating and set a $13.00 price objective on shares of Healthways in a research note on Tuesday, May 3rd. Finally, Zacks Investment Research raised shares of Healthways from a “sell” rating to a “hold” rating in a research note on Tuesday, May 3rd. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and two have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and an average price target of $13.40.

The company’s market capitalization is $608.60 million. The company has a 50-day moving average of $12.22 and a 200 day moving average of $11.55.

Healthways (NASDAQ:HWAY) last released its earnings results on Thursday, April 28th. The company reported ($0.08) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.02) by $0.06. The business had revenue of $189.20 million for the quarter, compared to analysts’ expectations of $185.68 million. The company’s revenue for the quarter was down .4% compared to the same quarter last year. During the same quarter last year, the firm posted ($0.05) earnings per share. On average, equities research analysts expect that Healthways Inc. will post $0.24 EPS for the current fiscal year.

A number of institutional investors recently added to or reduced their stakes in HWAY. BNP Paribas Arbitrage SA boosted its position in Healthways by 37.1% in the fourth quarter. BNP Paribas Arbitrage SA now owns 80,127 shares of the company’s stock valued at $1,031,000 after buying an additional 21,702 shares during the last quarter. Royce & Associates LLC boosted its position in Healthways by 25.2% in the fourth quarter. Royce & Associates LLC now owns 796,704 shares of the company’s stock valued at $10,254,000 after buying an additional 160,500 shares during the last quarter. Finally, American Capital Management Inc. boosted its position in Healthways by 4.0% in the fourth quarter. American Capital Management Inc. now owns 896,380 shares of the company’s stock valued at $11,536,000 after buying an additional 34,590 shares during the last quarter.

Healthways, Inc (Healthways) provides network delivered solutions and population health management services that are designed to help people manage their wellbeing, thereby managing their health and productivity, and their health-related costs. The Company operates in the domestic and international segments, which are collectively known as the well-being improvement services segment.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.